Skip to main content

Table 1 Demographic features of epileptic patient treated with carbamazepine monotherapy and seizures’ types

From: Epilepsy control with carbamazepine monotherapy from a genetic perspective

Variables 3rd months of carbamazepine therapy (n = 71) 6th months of carbamazepine therapy (n = 62)
Male, n (%) 34 (47.9) 28 (45.2)
Female, n (%) 37 (52.1) 34 (54.8)
Age (year) ± SD 17.7 ± 8.2 17.9 ± 8.6
Generalized Tonic Clonic Seizure, n (%) 46 (62.0) 44 (77.4)
Generalized Tonic Seizure, n (%) 4 (7.0) 1 (1.6)
Atonic Seizure, n (%) 2 (7.0) 2 (3.2)
Simple Partial Seizure, n (%) 5 (7.0) 3 (4.8)
Complex Partial Seizure, n (%) 4 (4.2) 3 (4.8)
Secondary Generalized Complex Seizure, n (%) 10 (7.0) 6 (9.7)